celecoxib has been researched along with Migraine Disorders in 7 studies
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "9% (25/282) of placebo-treated subjects reported a treatment-emergent adverse event (TEAE)." | 2.94 | Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. ( Brand-Schieber, E; Dodick, DW; Lipton, RB; Munjal, S; Tepper, SJ, 2020) |
| "Migraine is a common disabling condition that results in considerable socioeconomic loss." | 2.73 | Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. ( Loo, CY; Raymond, AA; Tan, HJ; Teh, HS, 2007) |
| "We present the first successful migraine headache treatment with therapy specifically targeting HSV infection." | 1.48 | Migraine Headache Treated with Famciclovir and Celecoxib: A Case Report. ( Morimoto, M; Napier, BL; Napier, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Woods, RH | 1 |
| Lipton, RB | 1 |
| Munjal, S | 1 |
| Brand-Schieber, E | 1 |
| Tepper, SJ | 1 |
| Dodick, DW | 1 |
| Schain, AJ | 1 |
| Melo-Carrillo, A | 1 |
| Ashina, S | 1 |
| Strassman, AM | 1 |
| Burstein, R | 1 |
| Napier, BL | 1 |
| Morimoto, M | 1 |
| Napier, E | 1 |
| Peres, MF | 1 |
| Silberstein, SD | 1 |
| Loo, CY | 1 |
| Tan, HJ | 1 |
| Teh, HS | 1 |
| Raymond, AA | 1 |
| Mathew, NT | 1 |
| Kailasam, J | 1 |
| Fischer, A | 1 |
2 trials available for celecoxib and Migraine Disorders
| Article | Year |
|---|---|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; M | 2020 |
Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Migraine Disorde | 2007 |
5 other studies available for celecoxib and Migraine Disorders
| Article | Year |
|---|---|
Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study.
Topics: Alopecia; Anticonvulsants; Biological Products; Botulinum Toxins, Type A; Calcitonin Gene-Related Pe | 2022 |
Celecoxib reduces cortical spreading depression-induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in terminating migraine attacks.
Topics: Animals; Arteries; Celecoxib; Cortical Spreading Depression; Dilatation; Female; Macrophage Activati | 2020 |
Migraine Headache Treated with Famciclovir and Celecoxib: A Case Report.
Topics: 2-Aminopurine; Antiviral Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Famciclovir; Female; Herpes | 2018 |
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Migraine Disorde | 2002 |
Responsiveness to celecoxib in chronic paroxysmal hemicrania.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Female; Humans; Migraine Disorders; Pyraz | 2000 |